ENTITY
Celltrion Pharm

Celltrion Pharm (068760 KS)

119
Analysis
Health Care • South Korea
Celltrion Pharm Inc. manufactures and sells pharmaceutical products. The Company products inclue drugs for for hepatic diseases, digestion, diabetes, cold and fever, anti-inflammatory, and veterinary medical products. Celltrion also provides pharmaceutical raw materials.
more
bearish•Celltrion Healthcare
•21 May 2019 09:07

Celltrion H Block Deals Priced at Floor: More Short Entry Points Should Be On the Way

This block deal was another nice exit point for Celltrion H short sellers to wrap up short position. Just, 6.5M offering was simply massive, and...

Logo
751 Views
Share
bearish•Celltrion Inc
•23 Oct 2018 02:44

Celltrion Placement Is Prelude to Merger: Initiate Pair Trade (Short Celltrion/Long Healthcare)

Do not take this deal. But you do not need to worry about it either as those recent short-sellers would already have taken the deal, probably at...

Logo
586 Views
Share
bullish•Celltrion Inc
•20 Sep 2018 07:54

Close Long/Short on Celltrion/Celltrion Healthcare: Market Mood on Placement Is Surprisingly Mild

Damage wasn't too harsh on Celltrion Healthcare (091990 KS). Both local institutions and foreign investors seem to have been much milder this time...

Logo
568 Views
Share
bearish•Celltrion Inc
•26 Jul 2018 11:26

Sell Celltrion Inc (068270 KS): Story Unravelling

UPDATE: J&J release Q2 results - 24th July 2018 J&J’s US Remicade sales were flat QoQ. This undermines the story that Celltrion Group is...

•04 Jun 2018 20:23

Japan & Korea @Smartkarma:  Autos, Toshiba, NTT, JDI, North Korean Détente, and Trump Trade

As these weekly summaries get written on a weekend we look at things on a Friday-to-Friday schedule but things move at a fast pace. Just a week can...

Logo
265 Views
Share
x